蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 2616|回复: 10
收起左侧

[其他] ISPE GAMP R&D and Clinical Systems SIG publish first Concept Paper

[复制链接]
药徒
发表于 2014-6-5 14:37:04 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x

As the pharmaceutical industry increasingly transitions from paper-based to computerized processes, the validation of these systems is also becoming a focus of inspections in the field of clinical trials. This has resulted in an increased need for guidances and guidelines concerning GCP-regulated systems, especially since these systems play a crucial role in the life cycle of medicinal products.
Currently, there are only a few guidelines in existence which explicitly address validation activities in the field of GCP. At the same time, there is a paucity of information regarding the practical execution of regulatory requirements. Because the system landscape found in the GCP field is characterized by heterogeneous systems with multiple interfaces and system components of differing complexity and configurability, it is necessary to find a validation approach that is flexible and scaleable.
GCP experts from the ISPE GAMP R&D and Clinical Systems SIG, led by Q-finity's CEO, have published a Concept Paper with the intention of harmonizing the GAMP 5 validation principles with GCP requirements, using the example of an Electronic Data Capture (EDC) system. The Concept Paper addresses the particular challenges to be dealt with when validating GCP-regulated systems. In the GCP field, there is no tangible product that results from the processes in place. Instead, the "product" is data, which is collected, processed and retained in different system components. Since this data forms the basis for the final analysis of the clinical trial, and with data integrity and patient safety at stake, the systems through which the data flow must be reliable.
By demonstrating the validation approach with a practical example, the application of the GAMP 5 principles to the GCP field are presented in a very comprehensible and concrete fashion.

GAMP GCP Concept-paper.pdf

1.85 MB, 阅读权限: 20, 下载次数: 139

售价: 1 金币  [记录]

评分

参与人数 1金币 +3 收起 理由
beiwei5du + 3

查看全部评分

回复

使用道具 举报

发表于 2014-6-5 20:36:45 | 显示全部楼层
好好学习,谢谢楼主
回复

使用道具 举报

药徒
发表于 2014-8-29 11:43:07 | 显示全部楼层
感谢分享。。。。
回复

使用道具 举报

药徒
发表于 2014-8-29 11:52:20 | 显示全部楼层
英文!!!!
回复

使用道具 举报

药徒
发表于 2016-10-9 21:15:38 | 显示全部楼层
THANKS FOR SHARING
回复

使用道具 举报

发表于 2017-7-25 13:12:37 | 显示全部楼层
谢谢楼主。
回复

使用道具 举报

药徒
发表于 2017-7-27 10:50:54 | 显示全部楼层
收到,谢谢分享
回复

使用道具 举报

药师
发表于 2020-11-15 21:50:58 | 显示全部楼层
感谢楼主分享!
回复

使用道具 举报

发表于 2020-11-16 08:24:35 来自手机 | 显示全部楼层
檔案不完整,無法下載
回复

使用道具 举报

药徒
发表于 2020-11-23 09:35:23 | 显示全部楼层
感谢分享,好人
回复

使用道具 举报

药王
发表于 2022-8-5 20:31:05 | 显示全部楼层
感谢分享。
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2025-9-9 03:44

Powered by Discuz! X3.4

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表